Cite

HARVARD Citation

    Wojciechowski, J. et al. (2022). Population PK and PD Analysis of Domagrozumab in Pediatric Patients with Duchenne Muscular Dystrophy. Clinical pharmacology & therapeutics. 112 (6), pp. 1291-1302. [Online]. 
  
Back to record